Tianjin Hemay Pharmaceutical Co., Ltd.

Bld. 12, Hui-Ying Industrial Park, Zhong-Huan West Road No.86, Airport Economic Zone, Tianjin, China

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

46.1%

Phase 1

38.5%

Phase 3

15.4%

Trial Status Distribution

Completed

69.2%

Recruiting

7.7%

Terminated

23.1%

Clinical Trials

Trials sponsored by this organization (13)

Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis

Phase 2

Completed

interventional

Aug 202290 participants

A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Phase 3

Completed

interventional

Jan 2022306 participants

A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer

Phase 3

Recruiting

interventional

Jan 2022339 participants

Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects

Phase 1

Completed

interventional

Apr 202112 participants

A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis

Phase 2

Completed

interventional

Mar 2021140 participants

A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease

Phase 2

Terminated

interventional

Nov 202089 participants

A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

Phase 2

Completed

interventional

Apr 2020148 participants

Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

Phase 2

Terminated

interventional

Aug 201970 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations